EG194588 Inhibitors
EG194588 inhibitors are a class of chemical compounds designed to specifically target and modulate the activity of a molecule or protein designated as EG194588. Although the exact biological function of EG194588 is not fully characterized, it is presumably a protein or enzyme involved in a specific cellular pathway, where it plays a critical role in the regulation of various biochemical processes. Inhibitors of EG194588 are developed to bind to this target, thereby interfering with its normal function, which may involve processes such as enzymatic activity, protein-protein interactions, or signaling cascades. These inhibitors are valuable tools for probing the function of EG194588 within its native biological context, helping researchers understand the molecular mechanisms in which this molecule is involved.
The mechanism of action for EG194588 inhibitors likely involves binding to specific active or allosteric sites on the EG194588 molecule, leading to a disruption in its normal activity. This binding could inhibit the catalytic function of the protein if it is an enzyme, or it could prevent EG194588 from interacting with its natural binding partners, thereby blocking the transmission of signals or the progression of a biochemical pathway. By inhibiting EG194588, these compounds allow researchers to explore the downstream effects of its inhibition, providing insights into its role in cellular processes such as metabolism, signal transduction, or structural regulation. Through detailed studies using EG194588 inhibitors, scientists can gain a deeper understanding of the biological pathways in which EG194588 is involved, offering clues about its importance in maintaining cellular homeostasis and the intricate networks that regulate cellular functions.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Direct inhibitor targeting Obox7 by intercalating into DNA and preventing RNA polymerase II from transcribing. Disrupts DNA-binding transcription factor activity and inhibits RNA polymerase II-specific and cis-regulatory region sequence-specific DNA binding. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Direct inhibitor binding to RNA polymerase II, inhibiting transcription. Impacts Obox7 by disrupting RNA polymerase II-specific DNA binding and hindering its regulatory role. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Cyclin-dependent kinase inhibitor indirectly affecting Obox7. Alters cell cycle progression, influencing the regulation of transcription by RNA polymerase II and impacting Obox7 expression in specific cellular stages. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Inhibitor impacting Obox7 indirectly through NF-κB signaling. Modulates transcriptional regulation by RNA polymerase II by influencing NF-κB, affecting Obox7 expression in a cellular context dependent manner. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
Antimetabolite inhibiting thymidylate synthase, indirectly affecting Obox7. Alters nucleotide synthesis, influencing RNA polymerase II-dependent transcriptional regulation, and impacting Obox7 expression in cellular contexts with active DNA replication. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
BET bromodomain inhibitor indirectly affecting Obox7 by modulating chromatin structure. Alters transcriptional regulation by RNA polymerase II, influencing Obox7 expression in specific cellular contexts dependent on chromatin accessibility. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor indirectly influencing Obox7 through protein synthesis regulation. Alters translation, impacting RNA polymerase II-dependent transcriptional regulation and affecting Obox7 expression in cellular contexts dependent on protein turnover. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitor indirectly affecting Obox7 through chromatin remodeling. Alters transcriptional regulation by RNA polymerase II, influencing Obox7 expression in cellular contexts dependent on histone acetylation dynamics. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $70.00 $198.00 | 18 | |
GSK-3 inhibitor indirectly affecting Obox7 through Wnt signaling modulation. Alters transcriptional regulation by RNA polymerase II, influencing Obox7 expression in cellular contexts dependent on Wnt pathway activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor indirectly affecting Obox7 through MAPK signaling modulation. Alters transcriptional regulation by RNA polymerase II, influencing Obox7 expression in cellular contexts dependent on JNK pathway activity. | ||||||